A detailed history of Valeo Financial Advisors, LLC transactions in Chimerix Inc stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 146,186 shares of CMRX stock, worth $575,972. This represents 0.01% of its overall portfolio holdings.

Number of Shares
146,186
Previous 81,766 78.79%
Holding current value
$575,972
Previous $76,000 568.42%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025

BUY
$0.83 - $3.48 $53,468 - $224,181
64,420 Added 78.79%
146,186 $508,000
Q3 2024

Oct 10, 2024

BUY
$0.77 - $1.07 $53,518 - $74,370
69,505 Added 566.88%
81,766 $76,000
Q2 2024

Jul 10, 2024

BUY
$0.87 - $1.05 $10,667 - $12,874
12,261 New
12,261 $10,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $345M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.